PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Childhood Infections and Vaccines of Children\'s Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.\', \'Emory Vaccine Center, Emory University, Atlanta, GA, USA.\', \'Yerkes National Primate Research Center, Atlanta, GA, USA.\', \'Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'National Institute of Allergy and Infectious Diseases, Vaccine Research Center, National Institutes of Health, Rockville, MD, USA.\', \'Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.\', \'Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1016/j.xcrm.2022.100529
?:doi
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 35233550
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all